205 related articles for article (PubMed ID: 30893781)
1. Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis.
Kardoust Parizi M; Iwata T; Kimura S; Janisch F; Abufaraj M; Karakiewicz PI; Enikeev D; Rapoport LM; Hutterer G; Shariat SF
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893781
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma.
Abrahamsson PA; Cockett AT; di Sant'Agnese PA
Prostate Suppl; 1998; 8():37-42. PubMed ID: 9690662
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of neuroendocrine differentiation in prostate adenocarcinoma.
Sagnak L; Topaloglu H; Ozok U; Ersoy H
Clin Genitourin Cancer; 2011 Dec; 9(2):73-80. PubMed ID: 22035833
[TBL] [Abstract][Full Text] [Related]
4. Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
Sainio M; Visakorpi T; Tolonen T; Ilvesaro J; Bova GS
Pathol Res Pract; 2018 Jun; 214(6):848-856. PubMed ID: 29728311
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors.
Genitsch V; Zlobec I; Seiler R; Thalmann GN; Fleischmann A
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788048
[TBL] [Abstract][Full Text] [Related]
6. Does Gleason score of positive surgical margin after radical prostatectomy affect biochemical recurrence and oncological outcomes? Protocol for systematic review.
John A; O'Callaghan M; Catterwell R; Selth L
BMJ Open; 2020 Mar; 10(3):e034612. PubMed ID: 32209629
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy.
May M; Siegsmund M; Hammermann F; Loy V; Gunia S
Scand J Urol Nephrol; 2007; 41(5):375-81. PubMed ID: 17853019
[TBL] [Abstract][Full Text] [Related]
8. Impact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysis.
Wu S; Lin X; Lin SX; Lu M; Deng T; Wang Z; Olumi AF; Dahl DM; Wang D; Blute ML; Wu CL
Scand J Urol; 2019 Oct; 53(5):287-294. PubMed ID: 31401922
[No Abstract] [Full Text] [Related]
9. Neuroendocrine differentiation in prostate cancer.
Cerović SJ; Brajusković GR; Vukotić Maletić VD; Mićić SR
Vojnosanit Pregl; 2004; 61(5):513-8. PubMed ID: 15551804
[TBL] [Abstract][Full Text] [Related]
10. Positive surgical margin is associated with biochemical recurrence risk following radical prostatectomy: a meta-analysis from high-quality retrospective cohort studies.
Zhang L; Wu B; Zha Z; Zhao H; Jiang Y; Yuan J
World J Surg Oncol; 2018 Jul; 16(1):124. PubMed ID: 29970100
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta-Analysis of 13,140 Patients.
Fahmy O; Khairul-Asri MG; Schubert T; Renninger M; Stenzl A; Gakis G
J Urol; 2017 Feb; 197(2):385-390. PubMed ID: 27569436
[TBL] [Abstract][Full Text] [Related]
12. Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer.
Revelos K; Petraki C; Scorilas A; Stefanakis S; Malovrouvas D; Alevizopoulos N; Kanellis G; Halapas A; Koutsilieris M
Anticancer Res; 2007; 27(5B):3651-60. PubMed ID: 17972531
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy in high-risk prostate cancer: incidence of specimen-confined disease (pT2-pT3a N0R0) and outcomes.
Mearini L; Nunzi E; Bini V; Lepri L; Bruno R; Porena M
Urologia; 2014; 81(2):125-32. PubMed ID: 24474543
[TBL] [Abstract][Full Text] [Related]
14. The role of radical prostatectomy for the treatment of metastatic prostate cancer: a systematic review and meta-analysis.
Wang Y; Qin Z; Wang Y; Chen C; Wang Y; Meng X; Song N
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29263146
[TBL] [Abstract][Full Text] [Related]
15. Close surgical margins after radical prostatectomy mimic biochemical recurrence rates of positive margins.
Whalen MJ; Shapiro EY; Rothberg MB; Turk AT; Woldu SL; Roy Choudhury A; Patel T; Badani KK
Urol Oncol; 2015 Nov; 33(11):494.e9-494.e14. PubMed ID: 26259665
[TBL] [Abstract][Full Text] [Related]
16. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
17. Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review.
Laukhtina E; Sari Motlagh R; Mori K; Quhal F; Schuettfort VM; Mostafaei H; Katayama S; Grossmann NC; Ploussard G; Karakiewicz PI; Briganti A; Abufaraj M; Enikeev D; Pradere B; Shariat SF
World J Urol; 2021 Nov; 39(11):4085-4099. PubMed ID: 34047825
[TBL] [Abstract][Full Text] [Related]
18. Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate.
Krupski T; Petroni GR; Frierson HF; Theodorescu JU
Urology; 2000 May; 55(5):743-9. PubMed ID: 10792093
[TBL] [Abstract][Full Text] [Related]
19. Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical margins.
Shapiro EY; Scarberry K; Patel T; Bergman A; Ahn JJ; Sahi N; RoyChoudhury A; Deutch I; McKiernan JM; Benson MC; Badani KK
J Endourol; 2014 Feb; 28(2):208-13. PubMed ID: 24044423
[TBL] [Abstract][Full Text] [Related]
20. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
